ArticleBiomedicines2026
Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy.
Şahin Bedir, Gülin Alkan Şen, Hamza Abbasov, Murad Guliyev, Erdem Sünger, Burçin Çakan Demirel, Nilay Şengül, Abdilkerim Oyman, Yakup Bozkaya, Ahmet Bilici and 3 more
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Şahin BedirDepartment of Medical Oncology, Gaziosmanpaşa Hastanesi, Istinye University, 34010 Istanbul, Turkey.ORCID 0000-0002-5797-0804 Gülin Alkan ŞenDepartment of Medical Oncology, Cerrahpasa Medical Faculty Hospital, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey.
Hamza AbbasovDepartment of Medical Oncology, Cerrahpasa Medical Faculty Hospital, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey.ORCID 0000-0003-1227-9996 Murad GuliyevDepartment of Medical Oncology, Cerrahpasa Medical Faculty Hospital, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey.
Erdem SüngerDepartment of Medical Oncology, Istanbul Medipol Mega University Hospital, Istanbul Medipol University, 34214 Istanbul, Turkey.ORCID 0000-0001-5194-1634 Burçin Çakan DemirelDepartment of Medical Oncology, Istanbul Medipol Mega University Hospital, Istanbul Medipol University, 34214 Istanbul, Turkey.ORCID 0000-0003-0734-0692 Nilay ŞengülDepartment of Medical Oncology, Medicana Ataköy Hospital, 34158 Istanbul, Turkey.
Abdilkerim OymanDepartment of Medical Oncology, Gaziosmanpaşa Hastanesi, Istinye University, 34010 Istanbul, Turkey.
Yakup BozkayaDepartment of Medical Oncology, Gaziosmanpaşa Hastanesi, Istinye University, 34010 Istanbul, Turkey.
Ahmet BiliciDepartment of Medical Oncology, Istanbul Medipol Mega University Hospital, Istanbul Medipol University, 34214 Istanbul, Turkey.
Hande TurnaDepartment of Medical Oncology, Cerrahpasa Medical Faculty Hospital, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey.ORCID 0000-0003-0558-9371 Mustafa ÖzgüroğluDepartment of Medical Oncology, Cerrahpasa Medical Faculty Hospital, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey.
Gökmen Umut ErdemDepartment of Medical Oncology, Istanbul Başakşehir Çam ve Sakura Şehir Hastanesi, 34480 Istanbul, Turkey.ORCID 0000-0002-3375-9465 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
immune checkpoint inhibitorsnon-small cell lung cancerprognostic biomarkers
Identifiers
PMID42652206
PMCPMC13509242
What OpenQuestion holds
Textmetadata
Read underepoch 390